Clinical Trial Update: Phase 1 Norwalk Vaccine Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of the Norovirus (Norwalk) vaccine developed by LigoCyte Pharmaceuticals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Norovirus Infection

Drugs mentioned

• Norwalk vaccine (Norovirus vaccine)

Snippet

Sponsor: LigoCyte Pharmaceuticals, Inc. | Conditions: Norovirus | Phase 1 | Status: COMPLETED